Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 20, 2021 07:50 ET | Source: BioNTech SE

Pfizer-BioNTech-COVID-19-Impfstoff induziert im Zellmodell Antikörper, die Pseudoviren mit dem Spike-Protein der U.K.-SARS-CoV-2-Variante neutralisieren

NEW YORK, USA und MAINZ, Deutschland, 20. Januar 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX) gaben heute die Ergebnisse einer in-vitro-Studie bekannt, die das...
January 20, 2021 07:50 ET | Source: BioNTech SE

Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture

New York and Mainz, Germany, January 20, 2021 — Today, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced results from an in vitro study that provides additional data on the capability...